COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 1152: Articles 11511-11520  | Next

Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients
Zeng, C., Evans, J. P., Reisinger, S., Woyach, J., Liscynesky, C., Boghdadly, Z. E., Rubinstein, M. P., Chakravarthy, K., Saif, L., Oltz, E. M., Gumina, R. J., Shields, P. G., Li, Z., Liu, S.-L.
10.1101/2021.10.20.21265273 — Posted: 2021-10-21
Wastewater-Based Epidemiological Modeling for Continuous Surveillance of COVID-19 Outbreak
Fazli, M., Sklar, S., Porter, M. D., French, B. A., Shakeri, H.
10.1101/2021.10.19.21265221 — Posted: 2021-10-20
Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities
Bierle, D. M., Ganesh, R., Tulledge-Scheitel, S. M., Hanson, S. N., Arndt, L. L., Wilker, C. G., Razonable, R. R.
10.1101/2021.10.19.21265222 — Posted: 2021-10-20
Modeling remdesivir antiviral efficacy in COVID-19 hospitalized patients of the randomized, controlled, open-label DisCoVeRy trial
Lingas, G., Neant, N., Gaymard, A., Belhadi, D., Peytavin, G., Hites, M., Staub, T., Greil, R., Paiva, J.-A., Poissy, J., Peiffer-Smadja, N., Costagliola, D., Yazdanpanah, Y., Wallet, F., Gagneux-Brunon, A., Mentre, F., Ader, F., Burdet, C., Guedj, J., Bouscambert-Duchamp, M., DisCoVeRy study group
10.1101/2021.10.19.21265209 — Posted: 2021-10-20
Evidence of transmission from fully vaccinated individuals in a large outbreak of the SARS-CoV-2 Delta variant in Provincetown, Massachusetts
Siddle, K. J., Krasilnikova, L. A., Moreno, G. K., Schaffner, S. F., Vostok, J., Fitzgerald, N. A., Lemieux, J. E., Barkas, N., Loreth, C., Specht, I., Tomkins-Tinch, C. H., Silbert, J., Schaeffer, B., Taylor, B. P., Loftness, B., Johnson, H., Schubert, P. L., Shephard, H. M., Doucette, M., Fink, T., Lang, A. S., Baez, S., Beauchamp, J., Hennigan, S., Buzby, E., Ash, S., Brown, J., Clancy, S., Cofsky, S., Gagne, L., Hall, J., Harrington, R., Gionet, G. L., DeRuff, K. C., Vodzak, M. E., Adams, G. C., Dobbins, S. T., Slack, S. D., Reilly, S. K., Anderson, L. M., Cipicchio, M. C., DeFelice, M. T., Grimsby, J. L., Anderson, S. E., Blumenstiel, B. S., Meldrim, J. C., Rooke, H. M., Vicente, G., Smith, N. L., Messer, K. S., Reagan, F. L., Mandese, Z. M., Lee, M. D., Ray, M. C., Fisher, M. E., Ulcena, M. A., Nolet, C. M., English, S. E., Larkin, K. L., Vernest, K., Chaluvadi, S., Arvidson, D., Melchiono, M., Covell, T., Harik, V., Brock-Fisher, T., Dunn, M., Kearns, A., Hanage, W. P., Bernard, C., Philippakis, A., Lennon, N. J., Gabriel, S. B., Gallagher, G. R., Smole, S., Madoff, L. C., Brown, C. M., Park, D. J., MacInnis, B. L., Sabeti, P. C.
10.1101/2021.10.20.21265137 — Posted: 2021-10-20 Discussion: Onsite
Airborne transmission of SARS-CoV-2 over distances greater than two metres: a rapid systematic review
Palmer, J. C., Duval, D., Tudge, I., Sarfo-Annin, J. K., Pearce-Smith, N., O'Connell, E., Bennett, A., Clark, R.
10.1101/2021.10.19.21265208 — Posted: 2021-10-20
Mutations on non-structural proteins of SARS-CoV-2 are possibly responsible for adverse clinical outcomes in a real-life practice
Ichikawa, T., Torii, S., Suzuki, H., Takada, A., Suzuki, S., Nakajima, M., Tampo, A., kakinoki, y.
10.1101/2021.10.19.21265062 — Posted: 2021-10-20
Modeling brings additional insights into the kinetics of SARS-CoV-2 neutralizing antibody
Prague, M., Clairon, Q., Guedj, J., Thiebaut, R.
10.1101/2021.10.13.21264693 — Posted: 2021-10-20
SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021
Marques, A., Sherrill-Mix, S., Everett, J. K., Reddy, S., Hokama, P., Roche, A. M., Hwang, Y., Glascock, A., Whiteside, S. A., Graham-Wooten, J., Khatib, L. A., Fitzgerald, A. S., Moustafa, A., Bianco, C., Rajagopal, S., Helton, J., Deming, R., Denu, L., Azad, A., Kitt, E., Coffin, S., Newbern, C., Mell, J. C., Planet, P. J., Badjatia, N., Wang, Z.-X., Cannuscio, C. C., Strelau, K., Jaskowiak-Barr, A., Cressman, L., Loughrey, S., Ganguly, A., Feldman, M. D., Collman, R. G., Rodino, K. G., Kelly, B. J., Bushman, F. D.
10.1101/2021.10.18.21264623 — Posted: 2021-10-20
SARS-CoV-2 variant transmission in a community-health population (Mexico City, Mexico)
Zhang, W., Martinez, M., Davis, B. D., Chen, S. S., Sincuir Martinez, J., Corona, C., Diaz, G., Makhoul, E., Heneidi, S., Goldberg, J., Plummer, J. T., Vail, E.
10.1101/2021.10.18.21264783 — Posted: 2021-10-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).